市場調查報告書
商品編碼
1215725
動物用疼痛管理藥的全球市場(2022年~2028年)Veterinary Pain Management Drugs Market 2022-2028 |
全球動物用疼痛管理藥的市場規模,在預測期間內預計以3.8%的年複合成長率大幅成長。
寵物所有者想維持動物的健康和福利的傾向增加,影響市場成長的著名企業對更好且個性化的藥物開發等,是促進全球動物用疼痛管理藥市場成長的要素。還有對罹患癌症和腹痛,神經病變性疼痛的家畜數量大幅度擴大,也帶給市場成長正面的影響。
本報告提供全球動物用疼痛管理藥市場相關調查分析,市場概要,各市場區隔、地區的市場分析,競爭情形,企業簡介等系統性資訊。
Title:Global Veterinary Pain Management Drugs Market Size, Share, and Trends Analysis Report, by Type (NSAIDs, Agonists, Anesthetics, Opioids, DMOADs, and Others), By Animal Type (Companion Animals and Livestock Animals), By Application (Osteoarthritis, Musculoskeletal Disorders, Cancer, and Others), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, and Others), Forecast Period (2022-2028).
The global veterinary pain management drugs market is anticipated to grow at a substantial CAGR of 3.8% during the forecast period. The global veterinary pain management drugs market growth is driven by the factors such as rising pet owners' inclination toward maintaining animal health and welfare, and the development of better-personalized drugs by prominent players operating in market growth. A significant increase in the livestock population suffering from cancer, and abdominal and neuropathic pain is also creating a positive scope for market growth. According to the American Veterinary Medical Association, nearly 1 in 4 dogs will, at some stage in their life, develop neoplasia. Almost half of the dogs over the age of 10 will develop cancer. Significant investment by pet owners in animal healthcare is the factor motivating drug manufacturers to increase their R&D activities for better drug development. As per the American Pet Products Association, in 2019, annual spending on pets reached nearly $95.7 billion, and animal product sales reached around $100 billion.
The global veterinary pain management drugs market is segmented based on type, animal type, application, and distribution channel. Based on type, the market is sub-segmented into NSAIDs, agonists, anesthetics, opioids, DMOAD, and others. Based on animal type, the market is bifurcated into companion animals and livestock animals. Based on application, the market is sub-segmented into osteoarthritis, musculoskeletal disorders, cancer, and others. Whereas based on distribution channels, the market is further categorized into veterinary hospitals, veterinary clinics, and others.
Geographically, the veterinary pain management drugs market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America is likely to hold the highest share in the market due to the huge consumption of dairy products that has surged the number of animals. That further led to the generation of animal diseases. Moreover, many companies in the region are launching new products in the market. For instance, in 2020, Carprofen Chewable Tablets was developed by Cronus Pharma Specialties and approved by the USFDA.
The major market players in the global veterinary pain management drugs market include Zoetis Inc., Merck & Co., Inc., BASF SE, Bayer AG, Boehringer Ingelheim International GmbH, Cargill Inc., Elanco Animal Health Inc., and Eli Lilly and Co., among others. The market players are also contributing significantly to the growth of the market by the adoption of various strategies including mergers and acquisitions, geographical expansion, partnerships, collaborations, and new product launches, to stay competitive in the market.
Research Methodology
The market study of the global veterinary pain management drugs is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to break down the market into various segments, and derive the total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macroeconomic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.
Secondary Sources Include:
The report provides an in-depth analysis of the market size and intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.
Market Segmentation
The Report Covers: